South Wales, July 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "DYSPLAI" on June 24. The details about the trademark application no. UK00004406973 published in the journal no. 2026/028 (July 10).
Dr. Osagie Izuogu filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Downloadable software; downloadable computer software; computer software platforms; software development tools; computer software development tools; artificial intelligence software; artificial intelligence and machine learning software; artificial intelligence software for analysis; bioinformatics software; scientific research software; all of the aforesaid for research use in the fields of bioinformatics, oncology research, molecular biology, genomics, transcriptomics, RNA sequencing data analysis, biomarker discovery, molecular cohort analysis and scientific research report generation; none of the aforesaid relating to broadcasting, media publishing, social media, audience engagement, live graphics, gaming, home automation, industrial automation, factory automation, image-recognition systems, content management software, internet messaging software or workflow software.
Class 42 : Software as a service [SaaS]; platform as a service [PaaS]; artificial intelligence as a service [AIaaS]; platforms for artificial intelligence as software as a service [SaaS]; software as a service [SaaS] featuring software for machine learning; software as a service [SaaS] featuring computer software platforms for artificial intelligence; cloud computing services; computer software development; computer software integration; computer-aided scientific analysis services; analysis in the field of molecular biology; biological research and analysis; biomedical research services; biotechnology research; biotechnological research; research relating to biotechnology; research in the field of artificial intelligence; research in the field of artificial intelligence technology; technology consultancy in the field of artificial intelligence; scientific research in the field of genetics and genetic engineering; all of the aforesaid for research use in the fields of bioinformatics, oncology research, molecular biology, genomics, transcriptomics, RNA sequencing data analysis, biomarker discovery, molecular cohort analysis and scientific research report generation; none of the aforesaid relating to broadcasting, media publishing, social media, audience engagement, live graphics, gaming, home automation, industrial automation, factory automation, image-recognition systems, content management software, internet messaging software or workflow software; none of the aforesaid being medical diagnostic services, treatment recommendation services, clinical decision-support services or patient management services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004406973
Disclaimer: Curated by HT Syndication.
